Kingworld Medicines Group Limited
1110.HK
Get informed when a big investor buys or sells
+ FollowMarket Cap$227.08M
Close$
$1.15
202.1% upside
Current Fair Value
202.1% upsideUndervalued by 202.1% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $227.08 Million |
|---|---|
| Enterprise Value | $551.46 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $0.02 |
| Beta | 0.86 |
| Outstanding Shares | 583,347,739 |
Return
| Return on Equity | 2.83% |
|---|---|
| Return on Assets | 1.30% |
| Return on Invested Capital | 11.69% |
Valuation & Multiples
| P/E Ratio | 17.34 |
|---|---|
| PEG | -499.21 |
| Price to Sales | 0.19 |
| Price to Book Ratio | 0.38 |
| Enterprise Value to Revenue | 0.32 |
| Enterprise Value to EBIT | 5.55 |
| Enterprise Value to Net Income | 32 |
| Total Debt to Enterprise | 0.91 |
| Debt to Equity | 0.84 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Kingworld Medicines Group Limited
711 employees
CEO: Li Sheng Zhao Kingworld Medicines Group Limited functions as an investment holding company primarily engaged in the distribution of imported, branded pharmaceutical and healthcare items. The company also supplies a range of medical products, health go...